Progress of G Protein-Coupled Estrogen Receptor in Cardiovascular System Diseases

Xiaoyi Peng

doi:10.62051/ijphmr.v2n3.09

Authors

Xiaoyi Peng

DOI:

https://doi.org/10.62051/ijphmr.v2n3.09

Keywords:

Estrogen, GPER, Signal transduction, Cardiovascular and cerebrovascular systems/diseases, Cardiovascular and cerebrovascular diseases

Abstract

Cardiovascular disease is one of the leading causes of death worldwide, and estrogen is thought to play a protective role in cardiovascular health. The mechanism of action and clinical significance of GPER, as an emerging class of estrogen receptors, in the cardiovascular system is being extensively studied. This elucidation of the signaling pathways and specific roles of GPER in cardiovascular diseases, i.e., the multiple roles of GPER in cardiovascular protection through the activation of multiple signaling pathways, provides new hopes and strategies for the prevention and treatment of cardiovascular diseases. The purpose of this article is to summarize the progress of research on GPER in the field of cardiovascular disease.

References

[1] Fontaine C, Morfoisse F, Tatin F, et al. The impact of estrogen receptor in arterial and lymphatic vascular diseases [J]. Int J Mol Sci, 2020, 21(9). 3244.

[2] Zhang LQ, Wei GZ. Current status of research on the relationship between estrogen and cardiovascular diseases [J]. Chinese Medical Journal,2005,85(28):2012-2015. DOI:10.3760/j:issn:0376-2491.2005.28.020.

[3] Revankar CM, Cimino DF, Sklar LA, et al. A transmembrane intracellular estrogen receptor mediates rapid cell signaling. Science, 2005, 307: 1625-30

[4] Carmeci C, Thompson DA, Ring HZ, et al. Identification of a gene (GPR30) with homology to the G-protein- coupled receptor superfamily associated with estrogen receptor expression in breast cancer. Genomics, 1997, 45:607-17

[5] Razandi M et a1. Cell memblane and nuclear estrogen receptors Rs originate from a single1rlmscript: studies of ERd and ER13expressed in Chinese hamster ovary cells. Mol Endocrinol, 1999, 13:307-319

[6] Zhang Xuejiao, Ji Hui, Tang Susu, et al. Role of estrogen receptors in central nervous system disorders [J]. Pharmaceutical Research, 2018, 37(4):221-225, 248. DOI: 10.13506/j.cnki.jpr.2018.04.010.

[7] Thomas P, Pang Y, Filardo EJ, et al. Identity of an estro-gen membrane receptor coupled to a G protein in human breast cancer cells [J]. Endocrinology, 2005, 146(2) :624-632.

[8] Wang X, Lu L, Tan Y, et al. GPR 30 reduces myocardial infarct area and fibrosis in female ovariectomised mice by activating the PI3K/AKT pathway [J]. Life Sci, 2019, 226:22-32.

[9] J Wang, E Chen. Research progress on the cardiovascular and cerebrovascular protective effects of estrogen receptor [J]. China Maternal and Child Health Research, 2024, 35(2):94-100. DOI: 10.3969/j.issn.1673-5293.2024.02.014.

[10] Luo J, Liu D. Does GPER really function as a G protein-coupled estrogen receptor in vivo? [J]. Frontiers in endocrinology, 2020, 11: 148.

[11] Yang D, Zhou Q, Labroska V, et al. G protein-coupled receptors: structure- and function-based drug discovery [J]. Signal transduction and targeted therapy, 2021, 6(1): 7.

[12] Prossnitz ER, Barton M. The G protein-coupled oestrogen receptor GPER in health and disease: an update. Nat Rev Endocrinol. 2023 Jul;19(7):407-424. doi: 10.1038/s41574-023-00822-7. Epub 2023 May 16. PMID: 37193881; PMCID: PMC10187525.

[13] Li X, Kuang W, Qiu Z, et al. G protein-coupled estrogen receptor: apromising therapeutic target for aldosterone-induced hypertension[J]. Frontiers in Endocrinology, 2023, 14: 1226458.

[14] Knowlton AA, Lee AR. Estrogen and the cardiovascular system [J]. Pharmacol Ther, 2012, 135(1): 54-70. DOI: 10. 1016/j. pharmthera.2012.03.007.

[15] Seok YM, Jang EJ, Reiser O, et al. 17beta-Estradiol induces vasorelaxation in a G-protein-coupled receptor 30-independent manner[J]. Naunyn Schmiedebergs Arch Pharmacol, 2012, 385(9):945-948. doi: 10. 1007/s00210-012-0770-y.

[16] Chakrabarti S, Davidge ST. G-protein coupled receptor 30 (GPR30): a novel regulator of endothelial inflammation [J]. PloS One, 2012, 7(12): e52357. DOI: 10. 1371/journal. pone. 0052357.

[17] Feng Z, Wang C, Jin Y, et al. Kaempferol-induced GPER upregulation attenuates atherosclerosis via the PI3K/AKT/Nrf2 pathway [J]. Pharmaceutical biology, 2021, 59(1): 1104-1114.

[18] Aryan L, Younessi D, Zargari M, et al. The role of estrogen receptors in cardiovascular disease [J]. International journal of molecular sciences, 2020, 21(12): 4314.

[19] Liu JT. The role of estrogen receptors in cardiovascular disease [J]. [21] Liu JT. Journal of Xi'an Jiaotong University (Medical Edition), 2015, 79(2):141-152.

[20] Zhang Zhujing, Deng Shengli. Progress in the study of the role of G protein-coupled estrogen receptor in the cardiovascular system [J]. International Journal of Anaesthesiology and Resuscitation, 2023, 44(4):443-448. DOI:10.3760/cma.j.cn321761-20220527-00789.

[21] Chen Yancun, Qian Hongyan, Shi Guixiu. Research progress on the role of GPR30 in inflammation [J]. China Health Standard Management, 2018, 9(16):140-142. DOI: 10.3969/j.issn.1674-9316.2018.16.070.

[22] Liu S, Hu L, Yang M. Progress of G protein-coupled estrogen receptor 1-mediated environmental estrogenic effects [J]. Journal of Ecotoxicology, 2016, 11(1):52- 60

[23] Zhang H. Post-ischemic GPER1 activation exerts a protective role in myocardial ischaemia-reperfusion injury by inhibiting apoptosis [D]. Henan: Xinxiang Medical College, 2016.

[24] Chai S, Liu K, Feng W, et al. Activation of G protein-coupled estrogen receptor protects intestine from ischemia/reperfusion injury in mice by protecting the crypt cell proliferation [J]. Clinical Science, 2019, 133(3): 449-464